IDPC discusses the alarming scale of the negative health impacts related to drug use described in the 2018 World Drug Report, but also the woefully inadequate provision of a range of scientifically proven interventions to counter these.
IDPC outlines the key issues for consideration by member states as they reflect on what has been achieved since the adoption of the 2009 Political Declaration and Plan of Action and the implications for the next phase of the international drug policy regime.
IDPC evaluates the impacts of drug policies implemented across the world over the past decade, assessing progress made towards the 2019 goals and concluding on the need to move away from punitive approaches.
This paper provides the latest available data on women incarcerated for drug offences in Latin America, highlights the key human rights challenges they face in the criminal justice system, and offers policy recommendations.
In this response, IDPC analyses the 2017 INCB Annual Report, paying special attention to its foreword, its thematic chapter on treatment, as well as the cross-cutting issues of health, human rights and cannabis policies.
The IDPC network outlines four key asks for member states towards ensuring that future drug policies are firmly situated within the UN priorities of protecting health and human rights, promoting development and advancing peace and security.
IDPC provides an overview of the intersections between human rights and drug control as enshrined in the UNGASS Outcome document, offering recommendations for a better coordination of these two spheres of international cooperation.
This paper seeks to contribute to understanding of existing policies related to harm reduction in Cambodia, as well as the challenges to and opportunities for improvement in order to reduce the health and socio-economic harms associated with drug use.
This Paper provides an analysis of critical public health problems for the Philippine prison population, in relation to HIV/AIDS and hepatitis C (HCV), and offers recommendations
for addressing these ‘twin epidemics.’